Description lansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. it is manufactured by tap pharmaceutical productsmechanism of action lansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine h2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (h+,k+)-atpase enzyme system at the secretory surface of the gastric parietal cell. because this enzyme system is regarded as the acid (proton) pump within the parietal cell, lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. this effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.